EI
MXCT icon

EFG International’s MaxCyte MXCT Stock Holding History

EFG International’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$886 Hold
1,261
– – ﹤0.01% 1024
2025
Q4 		$1.96K Buy
+1,261
New +$2.01K ﹤0.01% 847

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

EFG International's MXCT Position: Q1 2026 in Review

EFG International held its MaxCyte (MXCT) position steady in Q1 2026 at 1,261 shares worth $886. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

EFG International first reported a position in MXCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.96K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • EFG International held 1,261 shares of MaxCyte worth $886 as of Q1 2026.
  • EFG International left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of EFG International's portfolio in Q1 2026, its #1024 holding.
  • EFG International first reported a position in MaxCyte in Q4 2025 and has held it in 2 quarters since.
  • EFG International's MaxCyte position peaked at $1.96K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.